0001179110-21-010540.txt : 20211202
0001179110-21-010540.hdr.sgml : 20211202
20211202171559
ACCESSION NUMBER: 0001179110-21-010540
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211130
FILED AS OF DATE: 20211202
DATE AS OF CHANGE: 20211202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anand Kapila K
CENTRAL INDEX KEY: 0001679166
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 211467762
MAIL ADDRESS:
STREET 1: C/O EXTENDED STAY AMERICA, INC.
STREET 2: 11525 N. COMMUNITY HOUSE ROAD, SUITE 100
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
edgar.xml
FORM 4 -
X0306
4
2021-11-30
0
0001739104
Elanco Animal Health Inc
ELAN
0001679166
Anand Kapila K
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
1
0
0
0
Common Stock
2021-11-30
4
A
0
7307
0
A
26467
D
Deferred Stock Units
2021-11-30
4
A
0
166.7248
28.74
A
Common Stock
166.7248
1289.2367
D
Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.
/s/ Catherine Powell, as Attorney-in-Fact for Kapila K. Anand
2021-12-02